Benzinga | Sep 29, 2021 04:36PM EDT

NIH-Backed US Study Of Mixed COVID-19 Vaccines Regime To Conclude Soon: CNBC

* The National Institutes of Health (NIH) is close to concluding trials evaluating mix n match COVID-19 vaccines regime, reports CNBC.

* Related: US NIH Initiates Trial to Assess Mix-Match of COVID-19 Vaccine Booster Shots.

* White House chief medical advisor, Dr. Anthony Fauci, said that safety and efficacy data on pairing a primary COVID-19 shot from one manufacturer with boosters from another could be available within the next two weeks.

* The NIH is close to completing trials that mixed boosters and initial doses from Pfizer Inc (NYSE:PFE), Moderna Inc (NASDAQ:MRNA), and Johnson & Johnson (NYSE:JNJ), Fauci said at a White House Covid briefing.

* Though the Centers for Disease Control and Prevention authorized Pfizer's booster for seniors and the medically vulnerable.

* Data on Johnson & Johnson's mix-and-match study could be ready within a week, while Pfizer's trial might be completed by mid-October.

* Moderna's mix-and-match study data is already available, Fauci added.

* Related: UK Study Of COVID-19 Shots Mix-Match Shows Immune Response, Can Add Flexibility To Vaccination Programs.

* In May, interim data from the U.K. trial evaluating mixture of Oxford-AstraZeneca Plc (NASDAQ:AZN) vaccine and Pfizer - BioNTech SE (NASDAQ:BNTX) showed some short-lived side effects.

* Related Link: UK Study Answers Question If Two Doses Of COVID-19 Vaccines Can Be Mix-Matched?

* In July, the EU regulator also said to weigh mix-and-match booster COVID-19 shots.

* Related: EU Regulator Weighing Mix-And-Match, Boosters For COVID-19 Shots.

* Most recently, the U.K. also said that it is preparing for a mixed COVID-19 booster program.

* Also Read: UK Preps Up For 'Mix & Match' COVID-19 Booster Program.

* Photo by Johaehn from Pixabay